Anna Zettergren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Zettergren has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
- Inger Kull
Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden
5 shared publications Antonios Georgelis
Institute of Environmental Medicine, Karolinska Institutet , Stockholm
4 shared publications- Sandra Ekström
Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden
4 shared publications Anna Bergström
Institute of Environmental Medicine, Karolinska Institutet Stockholm Sweden
3 shared publications- Anna Bergström
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
3 shared publications Erik Melén
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet , Stockholm
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 55 (5)
Response rates and representativeness from birth to young adulthood in a Swedish birth cohort
Background: In birth-cohort studies, response rates generally decline over time. We aimed to evaluate representativeness and identify predictors of retention up to young adulthood in a population-based birth cohort originally focused on asthma and allergies. Methods: The Barn/Child, Allergy, Milieu, Stockholm, Epidemiology (BAMSE) birth cohort was established in 1994–6 in Stockholm, Sweden. We utilized data from questionnaires and Swedish registers to compare the characteristics of participants at age 24 years (n = 3064) with those of the original cohort (n = 4089) and the general population born in 1994–6 in Stockholm county (n = 68 378) and Sweden (n = 310 976). Logistic regression was used to identify predictors of retention at age 24 years. Results: The response rate declined over time and was higher in females than in males in adolescence and young adulthood (80.0% versus 70.0% at age 24 years). Compared with the original cohort, participants at age 24 years more often had dispensed asthma medications (6.6% versus 5.8%) and university education (52.6% versus 47.8%), but had less often a mother who smoked during pregnancy (9.6% versus 10.8%). Similar patterns were observed in comparisons with the general population. Female sex [odds ratio (OR) 1.75, 95% confidence interval (CI) 1.49–2.05] and high parental education (OR 1.33, 95% CI 1.12–1.59) were the predominant predictors of retention in the cohort. Conclusion: Female sex, higher socio-economic status, and asthma were predictive factors of retention in the cohort after 24 years. This may have influenced the observed prevalence rates of asthma and allergies, and associations between potential risk factors and outcomes associated with retention.
- 18 August 2026
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 55 (5)
Open AccessResponse rates and representativeness from birth to young adulthood in a Swedish birth cohort
Background: In birth-cohort studies, response rates generally decline over time. We aimed to evaluate representativeness and identify predictors of retention up to young adulthood in a population-based birth cohort originally focused on asthma and allergies. Methods: The Barn/Child, Allergy, Milieu, Stockholm, Epidemiology (BAMSE) birth cohort was established in 1994–6 in Stockholm, Sweden. We utilized data from questionnaires and Swedish registers to compare the characteristics of participants at age 24 years (n = 3064) with those of the original cohort (n = 4089) and the general population born in 1994–6 in Stockholm county (n = 68 378) and Sweden (n = 310 976). Logistic regression was used to identify predictors of retention at age 24 years. Results: The response rate declined over time and was higher in females than in males in adolescence and young adulthood (80.0% versus 70.0% at age 24 years). Compared with the original cohort, participants at age 24 years more often had dispensed asthma medications (6.6% versus 5.8%) and university education (52.6% versus 47.8%), but had less often a mother who smoked during pregnancy (9.6% versus 10.8%). Similar patterns were observed in comparisons with the general population. Female sex [odds ratio (OR) 1.75, 95% confidence interval (CI) 1.49–2.05] and high parental education (OR 1.33, 95% CI 1.12–1.59) were the predominant predictors of retention in the cohort. Conclusion: Female sex, higher socio-economic status, and asthma were predictive factors of retention in the cohort after 24 years. This may have influenced the observed prevalence rates of asthma and allergies, and associations between potential risk factors and outcomes associated with retention.
- Open Access
- 21 December 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (4) , 452-454
Early‐Life Secondhand Smoke Exposure and Development of Atopic Dermatitis up to Adulthood
- 21 December 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (4) , 452-454
Open AccessEarly‐Life Secondhand Smoke Exposure and Development of Atopic Dermatitis up to Adulthood
- Open Access
- 28 April 2025
- Published by Karolinska Institutet
Tobacco exposure and health : from fetal life to adulthood
Tobacco causes adverse effects on health from both active and passive exposure and in all stages of life. While health effects of tobacco have been extensively studied, the current state of knowledge in certain research areas is poor. As trends of tobacco products change, new questions arise. Additionally, some well researched topics still contain important knowledge gaps.In Study I, the aim was to assess the validity of self-reported use of cigarettes, snus and e-cigarettes among Swedish young adults. Questionnaire data on tobacco use was compared to levels of cotinine, a biomarker of nicotine use, in urine samples. Overall, we found high validity of self-reported tobacco use compared to cotinine levels in the study population, with low levels of underreported tobacco use. The agreement between self-reported tobacco use and cotinine was particularly high among daily users, while somewhat lower for occasional users.In Study II, the aim was to investigate cross-sectional associations between current snus use at 24 years and cardiometabolic health markers at 24 and 26 years in a Swedish birth cohort. Exclusive daily snus use was associated with higher body mass index (BMI) and waist circumference (WC) among women at 24 years, as well as with higher BMI at 26 years, as compared to non-tobacco users. Among men, using 24 cans of snus/week was associated with higher BMI at 26 years. No significant associations were observed between snus use and body fat %, glycemic status or blood pressure.In Study III, the aim was to assess the association between early-life secondhand smoke (SHS) exposure (from maternal smoking during pregnancy and/or parental smoking during infancy) and development of atopic dermatitis (AD). Parental smoking during infancy was associated with a higher risk of AD up to 24 years, and particularly a phenotype defined by persistent AD with childhood onset of symptoms. Additionally, the association was stronger for AD with concurrent Immunoglobin E sensitization. Maternal smoking during pregnancy was associated with an increased AD risk up to 24 years, although only among participants not exposed to parental smoking in infancy. Furthermore, we found no gene- environment interaction between early-life SHS exposure and loss-of-function mutations in the FLG gene.In Study IV, the aim was to investigate the long-term effects of early-life SHS on asthma and lung function, and to disentangle the effect from those of tobacco use in adolescence and/or young adulthood. Early-life SHS was associated with asthma up to 24 years, and the risk was particularly high during pre-school age. Early-life SHS was not associated with prevalent asthma at 24 years, while smoking in adolescence and/or young adulthood was associated with prevalent symptoms of wheeze. Early-life SHS exposure was associated with lower ratio between forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC), irrespective of adolescent and/or young adulthood smoking. Smoking at a young age was additionally associated with a lower FEV1/FVC, regardless of early-life SHS exposure. Furthermore, dual exposure to early-life SHS and snus use in adolescent and/or young adulthood was associated with a lower FEV1/FVC.The results of this thesis indicate that I) validity of self-reported tobacco use is high among Swedish young adults, II) snus use is associated with higher BMI and WC in young adults, particularly among women, but not with body fat %, glycemic status or blood pressure, III) early-life SHS exposure is associated with AD up to adulthood, and the association differs by disease phenotype but not by FLG mutations, and IV) early-life SHS exposure is associated with asthma and lower lung function up to adulthood, regardless of smoking in adolescence and/or young adulthood, and smoking at a young age is associated with prevalent wheeze and lower lung function regardless of early-life SHS exposure.List of scientific papersI. Zettergren A, Sompa S, Palmberg L, Ljungman P, Pershagen G, Andersson N, Lindh CH, Georgelis A, Kull I, Melén E, Ekström S, Bergström A. Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort. BMJ Open. 2023 Jul 12;13(7):e072582 https://doi.org/10.1136/bmjopen-2023-072582II. Zettergren A, Andersson N, Pershagen G, Lindh CH, Georgelis A, Kull I, Melen E, Ekstrom S, Ljungman P, Bergström A. Snus and cardiometabolic health markers among Swedish young adults. Nicotine & Tobacco Research. 2024 Nov 15:ntae267. https://doi.org/10.1093/ntr/ntae267III. Zettergren A, Andersson N, Merritt, AS, Kull I, Ljungman P, Melén E, Pershagen G, Lundin S, Johansson EK, Ballardini N, Ekström S, Bergstrom A. Early-life secondhand smoke exposure and development of atopic dermatitis up to adulthood. [Manuscript]IV. Zettergren A, Yu Z, Andersson N, Lindh CH, Merritt AS, Kull I, Pershagen G, Ljungman P, Melén E, Ekström S, Bergström A. Tobacco exposure from fetal life to adulthood and development of asthma and lung function. [Manuscript]
- 28 April 2025
- Published by Karolinska Institutet
Open AccessTobacco exposure and health : from fetal life to adulthood
Tobacco causes adverse effects on health from both active and passive exposure and in all stages of life. While health effects of tobacco have been extensively studied, the current state of knowledge in certain research areas is poor. As trends of tobacco products change, new questions arise. Additionally, some well researched topics still contain important knowledge gaps.In Study I, the aim was to assess the validity of self-reported use of cigarettes, snus and e-cigarettes among Swedish young adults. Questionnaire data on tobacco use was compared to levels of cotinine, a biomarker of nicotine use, in urine samples. Overall, we found high validity of self-reported tobacco use compared to cotinine levels in the study population, with low levels of underreported tobacco use. The agreement between self-reported tobacco use and cotinine was particularly high among daily users, while somewhat lower for occasional users.In Study II, the aim was to investigate cross-sectional associations between current snus use at 24 years and cardiometabolic health markers at 24 and 26 years in a Swedish birth cohort. Exclusive daily snus use was associated with higher body mass index (BMI) and waist circumference (WC) among women at 24 years, as well as with higher BMI at 26 years, as compared to non-tobacco users. Among men, using 24 cans of snus/week was associated with higher BMI at 26 years. No significant associations were observed between snus use and body fat %, glycemic status or blood pressure.In Study III, the aim was to assess the association between early-life secondhand smoke (SHS) exposure (from maternal smoking during pregnancy and/or parental smoking during infancy) and development of atopic dermatitis (AD). Parental smoking during infancy was associated with a higher risk of AD up to 24 years, and particularly a phenotype defined by persistent AD with childhood onset of symptoms. Additionally, the association was stronger for AD with concurrent Immunoglobin E sensitization. Maternal smoking during pregnancy was associated with an increased AD risk up to 24 years, although only among participants not exposed to parental smoking in infancy. Furthermore, we found no gene- environment interaction between early-life SHS exposure and loss-of-function mutations in the FLG gene.In Study IV, the aim was to investigate the long-term effects of early-life SHS on asthma and lung function, and to disentangle the effect from those of tobacco use in adolescence and/or young adulthood. Early-life SHS was associated with asthma up to 24 years, and the risk was particularly high during pre-school age. Early-life SHS was not associated with prevalent asthma at 24 years, while smoking in adolescence and/or young adulthood was associated with prevalent symptoms of wheeze. Early-life SHS exposure was associated with lower ratio between forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC), irrespective of adolescent and/or young adulthood smoking. Smoking at a young age was additionally associated with a lower FEV1/FVC, regardless of early-life SHS exposure. Furthermore, dual exposure to early-life SHS and snus use in adolescent and/or young adulthood was associated with a lower FEV1/FVC.The results of this thesis indicate that I) validity of self-reported tobacco use is high among Swedish young adults, II) snus use is associated with higher BMI and WC in young adults, particularly among women, but not with body fat %, glycemic status or blood pressure, III) early-life SHS exposure is associated with AD up to adulthood, and the association differs by disease phenotype but not by FLG mutations, and IV) early-life SHS exposure is associated with asthma and lower lung function up to adulthood, regardless of smoking in adolescence and/or young adulthood, and smoking at a young age is associated with prevalent wheeze and lower lung function regardless of early-life SHS exposure.List of scientific papersI. Zettergren A, Sompa S, Palmberg L, Ljungman P, Pershagen G, Andersson N, Lindh CH, Georgelis A, Kull I, Melén E, Ekström S, Bergström A. Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort. BMJ Open. 2023 Jul 12;13(7):e072582 https://doi.org/10.1136/bmjopen-2023-072582II. Zettergren A, Andersson N, Pershagen G, Lindh CH, Georgelis A, Kull I, Melen E, Ekstrom S, Ljungman P, Bergström A. Snus and cardiometabolic health markers among Swedish young adults. Nicotine & Tobacco Research. 2024 Nov 15:ntae267. https://doi.org/10.1093/ntr/ntae267III. Zettergren A, Andersson N, Merritt, AS, Kull I, Ljungman P, Melén E, Pershagen G, Lundin S, Johansson EK, Ballardini N, Ekström S, Bergstrom A. Early-life secondhand smoke exposure and development of atopic dermatitis up to adulthood. [Manuscript]IV. Zettergren A, Yu Z, Andersson N, Lindh CH, Merritt AS, Kull I, Pershagen G, Ljungman P, Melén E, Ekström S, Bergström A. Tobacco exposure from fetal life to adulthood and development of asthma and lung function. [Manuscript]
- Open Access
- 28 April 2025
- Published by Karolinska Institutet
Tobacco exposure and health : from fetal life to adulthood
Tobacco causes adverse effects on health from both active and passive exposure and in all stages of life. While health effects of tobacco have been extensively studied, the current state of knowledge in certain research areas is poor. As trends of tobacco products change, new questions arise. Additionally, some well researched topics still contain important knowledge gaps.In Study I, the aim was to assess the validity of self-reported use of cigarettes, snus and e-cigarettes among Swedish young adults. Questionnaire data on tobacco use was compared to levels of cotinine, a biomarker of nicotine use, in urine samples. Overall, we found high validity of self-reported tobacco use compared to cotinine levels in the study population, with low levels of underreported tobacco use. The agreement between self-reported tobacco use and cotinine was particularly high among daily users, while somewhat lower for occasional users.In Study II, the aim was to investigate cross-sectional associations between current snus use at 24 years and cardiometabolic health markers at 24 and 26 years in a Swedish birth cohort. Exclusive daily snus use was associated with higher body mass index (BMI) and waist circumference (WC) among women at 24 years, as well as with higher BMI at 26 years, as compared to non-tobacco users. Among men, using 24 cans of snus/week was associated with higher BMI at 26 years. No significant associations were observed between snus use and body fat %, glycemic status or blood pressure.In Study III, the aim was to assess the association between early-life secondhand smoke (SHS) exposure (from maternal smoking during pregnancy and/or parental smoking during infancy) and development of atopic dermatitis (AD). Parental smoking during infancy was associated with a higher risk of AD up to 24 years, and particularly a phenotype defined by persistent AD with childhood onset of symptoms. Additionally, the association was stronger for AD with concurrent Immunoglobin E sensitization. Maternal smoking during pregnancy was associated with an increased AD risk up to 24 years, although only among participants not exposed to parental smoking in infancy. Furthermore, we found no gene- environment interaction between early-life SHS exposure and loss-of-function mutations in the FLG gene.In Study IV, the aim was to investigate the long-term effects of early-life SHS on asthma and lung function, and to disentangle the effect from those of tobacco use in adolescence and/or young adulthood. Early-life SHS was associated with asthma up to 24 years, and the risk was particularly high during pre-school age. Early-life SHS was not associated with prevalent asthma at 24 years, while smoking in adolescence and/or young adulthood was associated with prevalent symptoms of wheeze. Early-life SHS exposure was associated with lower ratio between forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC), irrespective of adolescent and/or young adulthood smoking. Smoking at a young age was additionally associated with a lower FEV1/FVC, regardless of early-life SHS exposure. Furthermore, dual exposure to early-life SHS and snus use in adolescent and/or young adulthood was associated with a lower FEV1/FVC.The results of this thesis indicate that I) validity of self-reported tobacco use is high among Swedish young adults, II) snus use is associated with higher BMI and WC in young adults, particularly among women, but not with body fat %, glycemic status or blood pressure, III) early-life SHS exposure is associated with AD up to adulthood, and the association differs by disease phenotype but not by FLG mutations, and IV) early-life SHS exposure is associated with asthma and lower lung function up to adulthood, regardless of smoking in adolescence and/or young adulthood, and smoking at a young age is associated with prevalent wheeze and lower lung function regardless of early-life SHS exposure.List of scientific papersI. Zettergren A, Sompa S, Palmberg L, Ljungman P, Pershagen G, Andersson N, Lindh CH, Georgelis A, Kull I, Melén E, Ekström S, Bergström A. Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort. BMJ Open. 2023 Jul 12;13(7):e072582 https://doi.org/10.1136/bmjopen-2023-072582II. Zettergren A, Andersson N, Pershagen G, Lindh CH, Georgelis A, Kull I, Melen E, Ekstrom S, Ljungman P, Bergström A. Snus and cardiometabolic health markers among Swedish young adults. Nicotine & Tobacco Research. 2024 Nov 15:ntae267. https://doi.org/10.1093/ntr/ntae267III. Zettergren A, Andersson N, Merritt, AS, Kull I, Ljungman P, Melén E, Pershagen G, Lundin S, Johansson EK, Ballardini N, Ekström S, Bergstrom A. Early-life secondhand smoke exposure and development of atopic dermatitis up to adulthood. [Manuscript]IV. Zettergren A, Yu Z, Andersson N, Lindh CH, Merritt AS, Kull I, Pershagen G, Ljungman P, Melén E, Ekström S, Bergström A. Tobacco exposure from fetal life to adulthood and development of asthma and lung function. [Manuscript]
- 28 April 2025
- Published by Karolinska Institutet
Open AccessTobacco exposure and health : from fetal life to adulthood
Tobacco causes adverse effects on health from both active and passive exposure and in all stages of life. While health effects of tobacco have been extensively studied, the current state of knowledge in certain research areas is poor. As trends of tobacco products change, new questions arise. Additionally, some well researched topics still contain important knowledge gaps.In Study I, the aim was to assess the validity of self-reported use of cigarettes, snus and e-cigarettes among Swedish young adults. Questionnaire data on tobacco use was compared to levels of cotinine, a biomarker of nicotine use, in urine samples. Overall, we found high validity of self-reported tobacco use compared to cotinine levels in the study population, with low levels of underreported tobacco use. The agreement between self-reported tobacco use and cotinine was particularly high among daily users, while somewhat lower for occasional users.In Study II, the aim was to investigate cross-sectional associations between current snus use at 24 years and cardiometabolic health markers at 24 and 26 years in a Swedish birth cohort. Exclusive daily snus use was associated with higher body mass index (BMI) and waist circumference (WC) among women at 24 years, as well as with higher BMI at 26 years, as compared to non-tobacco users. Among men, using 24 cans of snus/week was associated with higher BMI at 26 years. No significant associations were observed between snus use and body fat %, glycemic status or blood pressure.In Study III, the aim was to assess the association between early-life secondhand smoke (SHS) exposure (from maternal smoking during pregnancy and/or parental smoking during infancy) and development of atopic dermatitis (AD). Parental smoking during infancy was associated with a higher risk of AD up to 24 years, and particularly a phenotype defined by persistent AD with childhood onset of symptoms. Additionally, the association was stronger for AD with concurrent Immunoglobin E sensitization. Maternal smoking during pregnancy was associated with an increased AD risk up to 24 years, although only among participants not exposed to parental smoking in infancy. Furthermore, we found no gene- environment interaction between early-life SHS exposure and loss-of-function mutations in the FLG gene.In Study IV, the aim was to investigate the long-term effects of early-life SHS on asthma and lung function, and to disentangle the effect from those of tobacco use in adolescence and/or young adulthood. Early-life SHS was associated with asthma up to 24 years, and the risk was particularly high during pre-school age. Early-life SHS was not associated with prevalent asthma at 24 years, while smoking in adolescence and/or young adulthood was associated with prevalent symptoms of wheeze. Early-life SHS exposure was associated with lower ratio between forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC), irrespective of adolescent and/or young adulthood smoking. Smoking at a young age was additionally associated with a lower FEV1/FVC, regardless of early-life SHS exposure. Furthermore, dual exposure to early-life SHS and snus use in adolescent and/or young adulthood was associated with a lower FEV1/FVC.The results of this thesis indicate that I) validity of self-reported tobacco use is high among Swedish young adults, II) snus use is associated with higher BMI and WC in young adults, particularly among women, but not with body fat %, glycemic status or blood pressure, III) early-life SHS exposure is associated with AD up to adulthood, and the association differs by disease phenotype but not by FLG mutations, and IV) early-life SHS exposure is associated with asthma and lower lung function up to adulthood, regardless of smoking in adolescence and/or young adulthood, and smoking at a young age is associated with prevalent wheeze and lower lung function regardless of early-life SHS exposure.List of scientific papersI. Zettergren A, Sompa S, Palmberg L, Ljungman P, Pershagen G, Andersson N, Lindh CH, Georgelis A, Kull I, Melén E, Ekström S, Bergström A. Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort. BMJ Open. 2023 Jul 12;13(7):e072582 https://doi.org/10.1136/bmjopen-2023-072582II. Zettergren A, Andersson N, Pershagen G, Lindh CH, Georgelis A, Kull I, Melen E, Ekstrom S, Ljungman P, Bergström A. Snus and cardiometabolic health markers among Swedish young adults. Nicotine & Tobacco Research. 2024 Nov 15:ntae267. https://doi.org/10.1093/ntr/ntae267III. Zettergren A, Andersson N, Merritt, AS, Kull I, Ljungman P, Melén E, Pershagen G, Lundin S, Johansson EK, Ballardini N, Ekström S, Bergstrom A. Early-life secondhand smoke exposure and development of atopic dermatitis up to adulthood. [Manuscript]IV. Zettergren A, Yu Z, Andersson N, Lindh CH, Merritt AS, Kull I, Pershagen G, Ljungman P, Melén E, Ekström S, Bergström A. Tobacco exposure from fetal life to adulthood and development of asthma and lung function. [Manuscript]
- Open Access
- 15 November 2024
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 27 (6) , 1098-1108
Snus and Cardiometabolic Health Markers Among Swedish Young Adults
Snus is suggested as a risk factor for cardiometabolic disease, but little is known about health effects in young populations, particularly in women. We aimed to investigate associations between snus and cardiometabolic health markers among young men and women. This study was conducted within the BAMSE birth cohort and included participants followed up around 24 years (n=2256) and 26 years (n=1011). Snus use was assessed at 24 years by questionnaires. Cardiometabolic health markers were recorded at clinical examinations at 24 and 26 years. Associations between snus use and cardiometabolic markers were assessed by multivariable linear regression. Snus was used by 6.4% (n=81) among women and 21.9% (n=219) among men. Compared to no tobacco use, daily exclusive snus use among women at 24 years was associated with higher body mass index (BMI) (adjusted β: 1.93 kg/m2, 95% CI: 0.54, 3.33) and waist circumference (WC) (aβ: 3.80 cm, 95% CI: 0.41, 7.18) at 24 years, and with higher BMI (aβ: 2.73 kg/m2, 95% CI: 0.53-4.93) at 26 years. Among men, using ≥4 cans/week was associated with increased BMI (aβ: 2.48 kg/m2, 95% CI: 0.73, 4.24) and a tendency toward increased body fat (aβ: 2.31%, 95% CI: -0.53, 5.14) at 26 years. Snus use was not associated with glycemic status or blood pressure. Our results suggest that snus is associated with increased BMI, and possibly other measures of adiposity, among young women and heavy using young men. Given the cross-sectional study design, the results should be interpreted with caution. We found cross-sectional associations between snus use and measures of increased adiposity in a cohort of Swedish young adults, including BMI and waist circumference among women and BMI among heavy snus using men. We did not find associations between snus use and body fat %, glycemic status or blood pressure. This is one of few studies to investigate health effect of snus among both women and men as well as cardiometabolic health markers in young adults. Given the recent trends of increased snus use among young adults, our findings highlight the need for further research on snus on cardiometabolic health.
- 15 November 2024
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 27 (6) , 1098-1108
Open AccessSnus and Cardiometabolic Health Markers Among Swedish Young Adults
Snus is suggested as a risk factor for cardiometabolic disease, but little is known about health effects in young populations, particularly in women. We aimed to investigate associations between snus and cardiometabolic health markers among young men and women. This study was conducted within the BAMSE birth cohort and included participants followed up around 24 years (n=2256) and 26 years (n=1011). Snus use was assessed at 24 years by questionnaires. Cardiometabolic health markers were recorded at clinical examinations at 24 and 26 years. Associations between snus use and cardiometabolic markers were assessed by multivariable linear regression. Snus was used by 6.4% (n=81) among women and 21.9% (n=219) among men. Compared to no tobacco use, daily exclusive snus use among women at 24 years was associated with higher body mass index (BMI) (adjusted β: 1.93 kg/m2, 95% CI: 0.54, 3.33) and waist circumference (WC) (aβ: 3.80 cm, 95% CI: 0.41, 7.18) at 24 years, and with higher BMI (aβ: 2.73 kg/m2, 95% CI: 0.53-4.93) at 26 years. Among men, using ≥4 cans/week was associated with increased BMI (aβ: 2.48 kg/m2, 95% CI: 0.73, 4.24) and a tendency toward increased body fat (aβ: 2.31%, 95% CI: -0.53, 5.14) at 26 years. Snus use was not associated with glycemic status or blood pressure. Our results suggest that snus is associated with increased BMI, and possibly other measures of adiposity, among young women and heavy using young men. Given the cross-sectional study design, the results should be interpreted with caution. We found cross-sectional associations between snus use and measures of increased adiposity in a cohort of Swedish young adults, including BMI and waist circumference among women and BMI among heavy snus using men. We did not find associations between snus use and body fat %, glycemic status or blood pressure. This is one of few studies to investigate health effect of snus among both women and men as well as cardiometabolic health markers in young adults. Given the recent trends of increased snus use among young adults, our findings highlight the need for further research on snus on cardiometabolic health.
- Open Access
Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort
Objectives Studies on health effects of tobacco often rely on self-reported exposure data, which is subjective and can lead to misclassification. The aim of this study was to describe the prevalence of cigarette smoking, snus and e-cigarette use, as well as to validate self-reported tobacco use among young adults in Sweden. Method Participants of a population-based Swedish cohort (n=3052), aged 22–25 years, assessed their tobacco use in a web questionnaire. Urinary cotinine was analysed in a subsample of the study population (n=998). The agreement between self-reported tobacco use and urinary cotinine was assessed using Cohen’s Kappa coefficient (κ) at a cut-off level of 50 ng/mL. Results Patterns of tobacco use differed between men and women. Among men, 20.0% reported daily snus use, 5.8% daily cigarette smoking and 5.6% any e-cigarette use. In contrast, 3.2% of the women reported daily snus use, 9.0% daily cigarette smoking and 2.4% any e-cigarette use. Among the tobacco use categories, daily snus users had the highest levels of cotinine. Of reported non-tobacco users, 3.5% had cotinine levels above the cut-off, compared with 68.0% among both occasional cigarette smokers and snus users, 67.5% among all e-cigarette users and 94.7% and 97.8% among daily cigarette smokers and snus users, respectively. Agreement between self-reported tobacco use and urinary cotinine was classified as strong for daily use of cigarettes (κ=0.824) and snus (κ=0.861), while moderate to weak for occasional smoking (κ=0.618), occasional snus use (κ=0.573) and any e-cigarette use (κ=0.576). Conclusions We found high validity of self-reported tobacco use in our study population, particularly for daily tobacco use. Further, we found that daily snus users were exposed to high levels of cotinine. Together with previous findings, our results indicate good validity of self-reported tobacco use among young adults.
Open AccessAssessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort
Objectives Studies on health effects of tobacco often rely on self-reported exposure data, which is subjective and can lead to misclassification. The aim of this study was to describe the prevalence of cigarette smoking, snus and e-cigarette use, as well as to validate self-reported tobacco use among young adults in Sweden. Method Participants of a population-based Swedish cohort (n=3052), aged 22–25 years, assessed their tobacco use in a web questionnaire. Urinary cotinine was analysed in a subsample of the study population (n=998). The agreement between self-reported tobacco use and urinary cotinine was assessed using Cohen’s Kappa coefficient (κ) at a cut-off level of 50 ng/mL. Results Patterns of tobacco use differed between men and women. Among men, 20.0% reported daily snus use, 5.8% daily cigarette smoking and 5.6% any e-cigarette use. In contrast, 3.2% of the women reported daily snus use, 9.0% daily cigarette smoking and 2.4% any e-cigarette use. Among the tobacco use categories, daily snus users had the highest levels of cotinine. Of reported non-tobacco users, 3.5% had cotinine levels above the cut-off, compared with 68.0% among both occasional cigarette smokers and snus users, 67.5% among all e-cigarette users and 94.7% and 97.8% among daily cigarette smokers and snus users, respectively. Agreement between self-reported tobacco use and urinary cotinine was classified as strong for daily use of cigarettes (κ=0.824) and snus (κ=0.861), while moderate to weak for occasional smoking (κ=0.618), occasional snus use (κ=0.573) and any e-cigarette use (κ=0.576). Conclusions We found high validity of self-reported tobacco use in our study population, particularly for daily tobacco use. Further, we found that daily snus users were exposed to high levels of cotinine. Together with previous findings, our results indicate good validity of self-reported tobacco use among young adults.
- Open Access
- 20 January 2022
- Published by Elsevier in Environmental Research
- Vol. 208, 112760
Predictors of electronic cigarette use and its association with respiratory health and obesity in young adulthood in Sweden; findings from the population-based birth cohort BAMSE
- 20 January 2022
- Published by Elsevier in Environmental Research
- Vol. 208, 112760
Open AccessPredictors of electronic cigarette use and its association with respiratory health and obesity in young adulthood in Sweden; findings from the population-based birth cohort BAMSE
- Open Access
Brain charts for the human lifespan
Over the past few decades, neuroimaging has become a ubiquitous tool in basic research and clinical studies of the human brain. However, no reference standards currently exist to quantify individual differences in neuroimaging metrics over time, in contrast to growth charts for anthropometric traits such as height and weight 1 . Here, we built an interactive resource to benchmark brain morphology, www.brainchart.io , derived from any current or future sample of magnetic resonance imaging (MRI) data. With the goal of basing these reference charts on the largest and most inclusive dataset available, we aggregated 123,984 MRI scans from 101,457 participants aged from 115 days post-conception through 100 postnatal years, across more than 100 primary research studies. Cerebrum tissue volumes and other global or regional MRI metrics were quantified by centile scores, relative to non-linear trajectories 2 of brain structural changes, and rates of change, over the lifespan. Brain charts identified previously unreported neurodevelopmental milestones 3 ; showed high stability of individual centile scores over longitudinal assessments; and demonstrated robustness to technical and methodological differences between primary studies. Centile scores showed increased heritability compared to non-centiled MRI phenotypes, and provided a standardised measure of atypical brain structure that revealed patterns of neuroanatomical variation across neurological and psychiatric disorders. In sum, brain charts are an essential first step towards robust quantification of individual deviations from normative trajectories in multiple, commonly-used neuroimaging phenotypes. Our collaborative study proves the principle that brain charts are achievable on a global scale over the entire lifespan, and applicable to analysis of diverse developmental and clinical effects on human brain structure. Furthermore, we provide open resources to support future advances towards adoption of brain charts as standards for quantitative benchmarking of typical or atypical brain MRI scans.
Open AccessBrain charts for the human lifespan
Over the past few decades, neuroimaging has become a ubiquitous tool in basic research and clinical studies of the human brain. However, no reference standards currently exist to quantify individual differences in neuroimaging metrics over time, in contrast to growth charts for anthropometric traits such as height and weight 1 . Here, we built an interactive resource to benchmark brain morphology, www.brainchart.io , derived from any current or future sample of magnetic resonance imaging (MRI) data. With the goal of basing these reference charts on the largest and most inclusive dataset available, we aggregated 123,984 MRI scans from 101,457 participants aged from 115 days post-conception through 100 postnatal years, across more than 100 primary research studies. Cerebrum tissue volumes and other global or regional MRI metrics were quantified by centile scores, relative to non-linear trajectories 2 of brain structural changes, and rates of change, over the lifespan. Brain charts identified previously unreported neurodevelopmental milestones 3 ; showed high stability of individual centile scores over longitudinal assessments; and demonstrated robustness to technical and methodological differences between primary studies. Centile scores showed increased heritability compared to non-centiled MRI phenotypes, and provided a standardised measure of atypical brain structure that revealed patterns of neuroanatomical variation across neurological and psychiatric disorders. In sum, brain charts are an essential first step towards robust quantification of individual deviations from normative trajectories in multiple, commonly-used neuroimaging phenotypes. Our collaborative study proves the principle that brain charts are achievable on a global scale over the entire lifespan, and applicable to analysis of diverse developmental and clinical effects on human brain structure. Furthermore, we provide open resources to support future advances towards adoption of brain charts as standards for quantitative benchmarking of typical or atypical brain MRI scans.
- Open Access
- 1 June 2021
- Published by Elsevier in Environmental Research
- Vol. 197, 111169
Low-level exposure to polycyclic aromatic hydrocarbons is associated with reduced lung function among Swedish young adults
- 1 June 2021
- Published by Elsevier in Environmental Research
- Vol. 197, 111169
Open AccessLow-level exposure to polycyclic aromatic hydrocarbons is associated with reduced lung function among Swedish young adults
- Open Access
- 1 January 2021
- Published by Elsevier in Environmental Research
- Vol. 192, 110249
Exposure to environmental phthalates during preschool age and obesity from childhood to young adulthood
- 1 January 2021
- Published by Elsevier in Environmental Research
- Vol. 192, 110249
Open AccessExposure to environmental phthalates during preschool age and obesity from childhood to young adulthood